Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 401–500 of 1,000
O’Connor, A. B., O’Brien, L. M., Alto, W. A., & Wong, J. J. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.987750 · Cited by 18
Counseling about risks of congenital anomalies from prescription opioids
Brennan, M., & Rayburn, W. F. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23064 · Cited by 18
Neonatal Abstinence Syndrome: The Experience of Infant Massage
Hahn, J., Lengerich, A. J., Byrd, R., Stoltz, R., Hench, J., Byrd, S., & Ford, C. (2016) · Creative Nursing · doi:10.1891/1078-4535.22.1.45 · Cited by 18
A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
Chisamore, B., Labana, S., Blitz, S., & Ordean, A. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s34550 · Cited by 18
Alcohol, smoking, and other substance use in the perinatal period
Wilson, C. A., Finch, E., Kerr, C., & Shakespeare, J. (2020) · BMJ · doi:10.1136/bmj.m1627 · Cited by 18
Fang, S.-Y., Huang, N., Lin, T. H., Ho, I., & Chen, C. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.044 · Cited by 18
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Parks, C. L., Fullerton, C. A., Kim, M. L., Montejano, L. B., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130309 · Cited by 18
Hill, S. L., & Thomas, S. H. L. (2016) · Medicine · doi:10.1016/j.mpmed.2015.12.030 · Cited by 18
Management and monitoring of opioid use in pregnancy
Rausgaard, N. L. K., Ibsen, I. O., Jørgensen, J. S., Lamont, R., & Ravn, P. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13677 · Cited by 18
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166565 · Cited by 17
Lessons learned from a comparison of evidence‐based research in pregnant opioid‐dependent women
Winklbaur, B., Jagsch, R., Graf‐Rohrmeister, K., Unger, A., Baewert, A., Langer, M., Thau, K., & Fischer, G. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2275 · Cited by 17
Self-citationConfounding of the Comparative Safety of Prenatal Opioid Agonist Therapy
Brogly, S. B., Hahn, K. A., Hernández–Díaz, S., & Werler, M. M. (2015) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000252 · Cited by 17
Opioid use disorder during pregnancy in Tennessee: expediency vs. science
Martin, P., & Finlayson, A. J. R. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1047502 · Cited by 17
Self-citationBabies breaking bad: neonatal and iatrogenic withdrawal syndromes
Cramton, R., & Gruchala, N. E. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328362cd0d · Cited by 20
The Role of Nurses in Comprehensive Care Management of Pregnant Women With Drug Addiction
McKeever, A. E., Spaeth-Brayton, S., & Sheerin, S. (2014) · Nursing for Women s Health · doi:10.1111/1751-486x.12134 · Cited by 17
Identification and Management of Prescription Drug Abuse in Pregnancy
Worley, J. (2014) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000039 · Cited by 18
Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder
Peeler, M., Fiscella, K. A., Terplan, M., & Sufrin, C. (2019) · Journal of Correctional Health Care · doi:10.1177/1078345818819855 · Cited by 17
Treating perinatal opioid use disorder in rural settings: Challenges and opportunities
Higgins, T. M., Goodman, D., & Meyer, M. C. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105786 · Cited by 17
van Hoogdalem, M. W., McPhail, B. T., Hahn, D., Wexelblatt, S. L., Akinbi, H. T., Vinks, A. A. T. M. M., & Mizuno, T. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1837112 · Cited by 17
Lopian, K. M., Chebolu, E., Kulak, J. A., Kahn, L. S., & Blondell, R. D. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.11.002 · Cited by 16
Pharmacologic Management of Cancer-Related Pain in Pregnant Patients
Zerfas, I., McGinn, R., & Smith, M. A. (2023) · Drugs · doi:10.1007/s40265-023-01906-4 · Cited by 16
Antenatal Opioid Exposure and Global and Regional Brain Volumes in Newborns
Wu, Y., Merhar, S. L., Bann, C., Newman, J. E., Kapse, K. J., Asis‐Cruz, J. D., Mack, N. A., Mauro, S. B. D., Ambalavanan, N., Davis, J. M., et al. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.0277 · Cited by 16
Baewert, A., Jagsch, R., Winklbaur, B., Kaiser, G., Thau, K., Unger, A., Aschauer, C., Weninger, M., & Metz, V. E. (2012) · European Addiction Research · doi:10.1159/000335082 · Cited by 16
Bhatt‐Mehta, V., Ng, C. M., & Schumacher, R. E. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182a12611 · Cited by 16
Opioid Use in Pregnant Women and the Increase in Neonatal Abstinence Syndrome: What Is the Cost?
Roussos-Ross, K., Reisfield, G. M., Elliot, I., Dalton, S., & Gold, M. S. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000122 · Cited by 17
Johnson, S., & Martin, P. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1363218 · Cited by 16
Self-citationWestgate, P. M., & Pomar, E. M. G. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00204 · Cited by 16
Opioid Management in Pregnancy and Postpartum
Brown, H. L. (2020) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2020.04.005 · Cited by 16
Women of Childbearing Age and Opioids
Smith, K. E., & Lipari, R. N. (2013) · Cited by 16
Escaping the Finnegan – Is it time?
Singh, R., & Davis, J. M. (2021) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2021.101218 · Cited by 16
Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19
Lensch, A. C., Hairston, E., Carter, G., & Jones, H. E. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000826 · Cited by 16
Self-citationIsaac, L., van den Hoogen, N. J., Habib, S., & Trang, T. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24811 · Cited by 16
Sedatives for opioid withdrawal in newborn infants
Zankl, A., Martin, J., Davey, J. G., & Osborn, D. A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002053.pub4 · Cited by 16
Sutter, M. B., Watson, H., Yonke, N., Weitzen, S. H., & Leeman, L. M. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03401-3 · Cited by 16
Pilarinos, A., Kwa, Y., Joe, R. S., Dong, H., Grant, C. C., Fast, D., Buxton, J. A., & DeBeck, K. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221136468 · Cited by 17
Prenatal and perinatal factors associated with neonatal neurobehavioral profiles in the ECHO Program
Camerota, M., McGowan, E. C., Aschner, J. L., Stroustrup, A., Karagas, M. R., Conradt, E. D., Crowell, S. E., Brennan, P. A., Carter, B. S., Check, J. F., et al. (2023) · Pediatric Research · doi:10.1038/s41390-023-02540-2 · Cited by 16
Lejeune, C., Genest, L., Miossec, E., Simonpoli, A.-M., & Simmat-Durand, L. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2012.11.014 · Cited by 16
Clinical presentation and management of neonatal abstinence syndrome: an update
Ordean, A., & Chisamore, B. (2014) · Research and Reports in Neonatology · doi:10.2147/rrn.s46441 · Cited by 17
Treatment of Perinatal Opioid Use Disorder
Boyars, L., & Guille, C. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.05.001 · Cited by 16
Trends and Outcomes Associated With Using Long-Acting Opioids During Delivery Hospitalizations
Duffy, C. R., Wright, J. D., Landau, R., Mourad, M., Siddiq, Z., Kern‐Goldberger, A. R., D’Alton, M. E., & Friedman, A. M. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002861 · Cited by 16
Dave, C. V., Goodin, A. J., Zhu, Y., Winterstein, A. G., Wang, X., Alrwisan, A. A., & Hartzema, A. G. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2315 · Cited by 16
Development of an abbreviated symptom score for the neonatal abstinence syndrome
Chervoneva, I., Adeniyi-Jones, S. C., Blanco, F. F., & Kraft, W. K. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-0606-4 · Cited by 16
Managing Pain during Pregnancy and Lactation
Nagpal, G., & Rathmell, J. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08340-9.00035-9 · Cited by 16
Impact of opioid therapy on gonadal hormones: focus on buprenorphine
Varma, A., Sapra, M., & Iranmanesh, A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0080 · Cited by 15
Sahid, A. S., Bebbington, M. J., Marcus, A., Baracz, S. J., Zimmermann, K. S., Oei, J. L., Ward, M. C., & Clemens, K. J. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111255 · Cited by 15
Comprehensive and compassionate responses for opioid use disorder among pregnant and parenting women
Hand, D. J., Fischer, A. C., Gannon, M. A., McLaughlin, K. A., Short, V. L., & Abatemarco, D. J. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1908966 · Cited by 15
Treating Opioid Use Disorder in General Medical Settings
(2021) · Springer eBooks · doi:10.1007/978-3-030-80818-1 · Cited by 15
Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
Coish, R., & Hardial, J. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001042 · Cited by 15
Dwivedi, I., Caldwell, A. B., Zhou, D., Wu, W., Subramaniam, S., & Haddad, G. G. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02397-3 · Cited by 15
Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine
Kushnir, A., Bhavsar, R., Hanna, E. S., & Hegyi, T. (2023) · Children · doi:10.3390/children10061030 · Cited by 15
The American Opioid Epidemic in Special Populations: Five Examples
Blanco, C., Ali, M. M., Beswick, A., Drexler, K. P. G., Hoffman, C., Jones, C. M., Wiley, T., & Coukell, A. J. (2020) · NAM Perspectives · doi:10.31478/202010b · Cited by 15
Growth failure in infants with neonatal abstinence syndrome in the neonatal intensive care unit
Favara, M. T., Smith, J. T., Friedman, D., Lafferty, M. A., Carola, D. L., Adeniyi-Jones, S. C., Greenspan, J. S., & Aghai, Z. H. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01183-7 · Cited by 15
Buprenorphine exposure in infants of opioid‐dependent mothers at birth
Bartu, A. E., Ilett, K. F., Hackett, L. P., Doherty, D. A., & Hamilton, D. (2012) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2012.01424.x · Cited by 15
Casper, T., & Arbour, M. W. (2013) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12087 · Cited by 15
Mittal, L. P., & Suzuki, J. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1129525 · Cited by 15
Shirel, T., Hubler, C., Shah, R., Mager, A., Koch, K. L., Sheth, D., Uhing, M. R., Jones, C., & Field, J. J. (2016) · American Journal of Hematology · doi:10.1002/ajh.24307 · Cited by 15
A review of the safety of buprenorphine in special populations
Brandt, C., & Atkinson, T. J. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.06.025 · Cited by 14
Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes
Krishnapura, S. R., McNeer, E. A., Loch, S. F., Reese, T., Dudley, J. A., Phillippi, J. C., Wiese, A. D., Dupont, W. D., Leech, A. A., & Patrick, S. W. (2025) · JAMA Health Forum · doi:10.1001/jamahealthforum.2025.1814 · Cited by 15
Schuetze, P. A., Godleski, S. A., & Sassaman, J. N. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.107019 · Cited by 14
Under-representation of key demographic groups in opioid use disorder trials
Rudolph, K. E., Russell, M., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100084 · Cited by 14
Manigault, A. W., Sheinkopf, S. J., Silverman, H. F., & Lester, B. M. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.38783 · Cited by 14
Care of Drug-Addicted Pregnant Women: Current Concepts and Future Strategies – an Overview
Goettler, S. M., & Tschudin, S. (2014) · Women s Health · doi:10.2217/whe.14.7 · Cited by 14
Neonatal abstinence syndrome and the gastrointestinal tract
Maguire, D. J., & Groer, M. E. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.10.006 · Cited by 14
Methadone, Pierre Robin sequence and other congenital anomalies: case–control study
Cleary, B., Loane, M. A., Addor, M., Barišić, I., de Walle, H. E. K., Dias, C. M., Gatt, M., Klungsøyr, K., McDonnell, B., Neville, A. J., et al. (2019) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2019-316804 · Cited by 14
Lee, J., Chen, J., Eisler, L. D., Li, G., Davis, J. M., & Sun, L. S. (2019) · Journal of Perinatology · doi:10.1038/s41372-019-0437-3 · Cited by 14
Labella, M. H., Eiden, R. D., Roben, C. K. P., & Dozier, M. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.675866 · Cited by 14
Holbrook, A. M., & Nguyen, V. H. (2015) · Journal of the Society for Social Work and Research · doi:10.1086/680232 · Cited by 14
Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient
Pan, A., & Zakowski, M. I. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000288 · Cited by 14
The Worldwide Opioid Epidemic: Implications for Treatment and Research in Pregnancy and the Newborn
Knoppert, D. C. (2011) · Pediatric Drugs · doi:10.2165/11592700-000000000-00000 · Cited by 14
Opioids and Opiates: Pharmacology, Abuse, and Addiction
Cruz, S. L., & Granados‐Soto, V. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3474-4_156 · Cited by 13
Lin, C.-W. G., Bateman, B. T., Straub, L., Hernández–Díaz, S., Vine, S. M., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B. M., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20241127 · Cited by 13
Self-citationWinhusen, T. M., Lofwall, M. R., Kropp, F. B., Lewis, D. F., Smid, M. C., Young, J. L., Hodgkins, C. C., Krans, E. E., Hansen, Z., Wachman, E. M., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2026.0057 · Cited by 13
Straub, L., Huybrechts, K. F., Hernández–Díaz, S., Zhu, Y., Vine, S. M., Desai, R. J., Gray, K. J., & Bateman, B. T. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab249 · Cited by 13
Treatment access for opioid use disorder among women with medicaid in Florida
Elmore, A. L., Patrick, S. W., McNeer, E. A., Fryer, K. E., Reid, C. N., Sappenfield, W. M., Mehra, S., Salemi, J. L., & Marshall, J. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109854 · Cited by 13
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
Miller, J. C., Brooks, M. A., Wurzel, K. E., Cox, E. J., & Wurzel, J. F. (2023) · Drugs in R&D · doi:10.1007/s40268-023-00443-5 · Cited by 13
Myers, A. M., Wallin, C. M., Richardson, L. M., Duran, J., Neole, S. R., Kulaglic, N., Davidson, C., Perrine, S. A., Bowen, S. E., & Brummelte, S. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110060 · Cited by 13
Gordon, A. L., Lopatko, O. V., Haslam, R. R., Stacey, H., Pearson, V., Woods, A., Fisk, A., & White, J. M. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000190 · Cited by 13
Wachman, E. M., Wang, A., Isley, B. C., Boateng, J. O., Beierle, J. A., Hansbury, A., Shrestha, H., Bryant, C. D., & Zhang, H. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00009 · Cited by 13
Barriers to employment for drug dependent postpartum women
Bowden, K., & Goodman, D. (2015) · Work · doi:10.3233/wor-141951 · Cited by 13
Management of opioid substitution therapy during medical intervention
Murnion, B. P. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02714.x · Cited by 13
Chen, C., Li, X., Ma, L., Wu, P., Zhou, Y. F., Feng, Q., & Cui, Y. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1955 · Cited by 13
Opioid Use Disorders and Pregnancy
Johnson, A. J., & Jones, C. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.01.008 · Cited by 13
The Effects of Neonatal Abstinence Syndrome on Language Delay from Birth to 10 Years
Miller, J. S., Anderson, J. G., Erwin, P. C., Davis, S. K., & Lindley, L. C. (2020) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2019.12.011 · Cited by 13
Buprenorphine for the Treatment of Opioid Dependence in Pregnancy
Mittal, L. P. (2014) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000044 · Cited by 13
Substance Abuse/Dependence Treatment: A European Perspective
Metz, V. E., Brandt, L., Unger, A., & Fischer, G. (2014) · Substance Abuse · doi:10.1080/08897077.2014.909377 · Cited by 13
Self-citationSubstance misuse problems during pregnancy with special emphasis on buprenorphine
Kahila, H. K. (2011) · Helda - University of Helsinki Institutional Repository · Cited by 13
Frontline Perspectives on Buprenorphine for the Management of Chronic Pain
Adler, J. A., Mallick‐Searle, T., Garofoli, M., & Zimmerman, A. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s449748 · Cited by 12
Fecal Incontinence and Diarrhea During Pregnancy
Menees, S. B., Lembo, A. J., & Charabaty, A. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001964 · Cited by 12
Devlin, L. A., Hu, Z., Ounpraseuth, S., Simon, A. E., Annett, R. D., Das, A., Fuller, J. F., Higgins, R. D., Merhar, S. L., Smith, P. B., et al. (2023) · Maternal and Child Health Journal · doi:10.1007/s10995-022-03521-3 · Cited by 12
Shah, D., Brown, S. D., Hagemeier, N., Zheng, S., Kyle, A. R., Pryor, J. R., Dankhara, N., & Singh, P. (2016) · SpringerPlus · doi:10.1186/s40064-016-2576-8 · Cited by 12
Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation
Liao, M. Z., Gao, C., Phillips, B., Neradugomma, N. K., Han, L. W., Bhatt, D. K., Prasad, B., Shen, D. D., & Mao, Q. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.076745 · Cited by 12
Medication for the Treatment of Opioid Use Disorder
Renner, J. A., & Crawford, M. B. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_5 · Cited by 12
Is Maternal Methadone Dose Associated with the Severity of Neonatal Abstinence Syndrome?
Smith, J. T., Lafferty, M. A., Boelig, R. C., Carola, D. L., Adeniyi-Jones, S. C., Kraft, W. K., Greenspan, J. S., & Aghai, Z. H. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1721693 · Cited by 12
Wang, S., Meador, K. J., Pawasauskas, J. E., Lewkowitz, A. K., Ward, K. E., Brothers, T. N., Hartzema, A. G., Quilliam, B. J., & Wen, X. (2023) · Drug Safety · doi:10.1007/s40264-022-01267-z · Cited by 12
Jones, H. E. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00229.x · Cited by 12
Self-citationWinhusen, T. M., Wilder, C. M., Wexelblatt, S. L., Theobald, J., Hall, E. S., Lewis, D. F., Hook, J. W. V., & Marcotte, M. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.08.009 · Cited by 12
Systematic Review of Interventions for Racial/Ethnic-Minority Pregnant Smokers
Washio, Y., & Cassey, H. (2014) · The Journal of Smoking Cessation · doi:10.1017/jsc.2014.12 · Cited by 12
Rosen, D. A., & Dower, J. (2011) · Pediatric Annals · doi:10.3928/00904481-20110412-05 · Cited by 12
Volkow (2016) · doi:10.1136/bmj.i19 · Cited by 11
Lim, G., Carvalho, B., George, R. B., Bateman, B. T., Brummett, C. M., Ip, V. H. Y., Landau, R., Osmundson, S. S., Raymond, B. L., Richebé, P., et al. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.12.006 · Cited by 11
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.